Log Type Authored on Log Message Log Node Authored by
OWA Status Check:23684:trialbaydoc@bigpond.com:47AF5528-E4DE-B6AA-34C3-B3753A0E8029:Updating trust level from [2] to [4] Anonymous
OWA Status Check:23605:admin@ballajuramedical.com.au:05ADE80E-943B-3F62-D0CD-8E26FF417E6C:Updating trust level from [2] to [4] Anonymous
OWA Status Check:23593:chesteromana@gmail.com:584F7769-EC67-E585-5971-D0D8F28C0C86:Updating trust level from [2] to [4] Anonymous
OWA Status Updating trust level from 1 to 0 Anonymous
User created User created Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter subscribed Newsletter subscribed - Newsletter de Progress in Mind España Anonymous
User created User created Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created User created Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Japan newsletter Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Estratégias na esquizofrenia - Aderente à adesão Anonymous
Newsletter clicked Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Log Type Authored on Log Message Log Node Authored by
OWA Status Check:23684:trialbaydoc@bigpond.com:47AF5528-E4DE-B6AA-34C3-B3753A0E8029:Updating trust level from [2] to [4] Anonymous
OWA Status Check:23605:admin@ballajuramedical.com.au:05ADE80E-943B-3F62-D0CD-8E26FF417E6C:Updating trust level from [2] to [4] Anonymous
OWA Status Check:23593:chesteromana@gmail.com:584F7769-EC67-E585-5971-D0D8F28C0C86:Updating trust level from [2] to [4] Anonymous
OWA Status Updating trust level from 1 to 0 Anonymous
User created User created Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind SEA Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter subscribed Newsletter subscribed - Newsletter de Progress in Mind España Anonymous
User created User created Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created User created Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Japan newsletter Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Atualize-se com a Progress in Mind Brazil Anonymous
Newsletter opened Opened Estratégias na esquizofrenia - Aderente à adesão Anonymous
Newsletter clicked Clicked https://brazil.progress.im/pt-br/page/pol%C3%ADtica-de-privacidade-e-prote%C3%A7%C3%A3o-de-dados Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous